Animal Vaccines Market Research Report by Product (Attenuated Live Vaccines, DNA Vaccines, and Inactivated Vaccines), by Animal Type (Aqua, Companion, and Poultry), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to

Animal Vaccines Market Research Report by Product (Attenuated Live Vaccines, DNA Vaccines, and Inactivated Vaccines), by Animal Type (Aqua, Companion, and Poultry), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

The Global Animal Vaccines Market size was estimated at USD 12,982.56 million in 2020 and expected to reach USD 14,005.47 million in 2021, at a CAGR 8.21% to reach USD 20,849.93 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Animal Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Subunit Vaccines.

Based on Animal Type, the market was studied across Aqua, Companion, Poultry, and Ruminants. The Aqua is further studied across Aeromonas, Streptococcosis, and Vibrio. The Companion is further studied across Canine and Feline. The Canine is further studied across Canine Herpes, Distemper, Kennel Cough, Lyme Disease, Parvovirus, and Rabies Canine. The Feline is further studied across Calicivirus, Coronavirus Feline, Panleukopenia, Rabies Feline, and Rhinotracheitis. The Poultry is further studied across Avian Influenza, Infectious Bronchitis, Marek's Disease, Newcastle Disease, and Salmonella. The Ruminants is further studied across Coronavirus Ruminants, E. Coli, Foot & mouth disease (FMD), Lumpy skin, and Rotavirus.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Vaccines Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Animal Vaccines Market, including Anicon Labor GmbH by SNA group, Biogénesis Bagó S.A., Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private limited, Ceva Santé Animale, China Animal Husbandry Industry Co., Ltd., Elanco LLC, Endovac Animal Health, LLC, Heska Corporation, Hester Biosciences Limited, HIPRA, S.A., Indian Immunologicals Limited, Merck KGaA, Neogen Corporation, Phibro Animal Health Corporation, Sanofi S.A., Torigen Pharmaceuticals Inc., Vaxxinova GmbH, VEROVACCiNES GmbH, Vetoquinol SA, Virbac, Inc., and Zoetis Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Animal Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Animal Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Animal Vaccines Market?
4. What is the competitive strategic window for opportunities in the Global Animal Vaccines Market?
5. What are the technology trends and regulatory frameworks in the Global Animal Vaccines Market?
6. What is the market share of the leading vendors in the Global Animal Vaccines Market?
7. What modes and strategic moves are considered suitable for entering the Global Animal Vaccines Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Growing Livestock Population
5.2.2. Rising Animal Husbandry along with Commercialization of Animal Products
5.2.3. Increasing Incidences of Zoonotic Diseases
5.3. Restraints
5.3.1. Supply End Costs are Relatively High, with Poorer Capital Returns than Human Vaccines
5.4. Opportunities
5.4.1. Shift from Live Attenuated Vaccines to DNA Vaccines
5.4.2. Continuous Technological Advancements in Vaccines
5.5. Challenges
5.5.1. Adverse Impacts of Vaccines
6. Animal Vaccines Market, by Product
6.1. Introduction
6.2. Attenuated Live Vaccines
6.3. DNA Vaccines
6.4. Inactivated Vaccines
6.5. Recombinant Vaccines
6.6. Subunit Vaccines
7. Animal Vaccines Market, by Animal Type
7.1. Introduction
7.2. Aqua
7.2.1. Aeromonas
7.2.2. Streptococcosis
7.2.3. Vibrio
7.3. Companion
7.3.1. Canine
7.3.1.1. Canine Herpes
7.3.1.2. Distemper
7.3.1.3. Kennel Cough
7.3.1.4. Lyme Disease
7.3.1.5. Parvovirus
7.3.1.6. Rabies Canine
7.3.2. Feline
7.3.2.1. Calicivirus
7.3.2.2. Coronavirus Feline
7.3.2.3. Panleukopenia
7.3.2.4. Rabies Feline
7.3.2.5. Rhinotracheitis
7.4. Poultry
7.4.1. Avian Influenza
7.4.2. Infectious Bronchitis
7.4.3. Marek's Disease
7.4.4. Newcastle Disease
7.4.5. Salmonella
7.5. Ruminants
7.5.1. Coronavirus Ruminants
7.5.2. E. Coli
7.5.3. Foot & mouth disease (FMD)
7.5.4. Lumpy skin
7.5.5. Rotavirus
8. Americas Animal Vaccines Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Animal Vaccines Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand
10. Europe, Middle East & Africa Animal Vaccines Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Anicon Labor GmbH by SNA group
12.2. Biogénesis Bagó S.A.
12.3. Boehringer Ingelheim International GmbH
12.4. Brilliant Bio Pharma Private limited
12.5. Ceva Santé Animale
12.6. China Animal Husbandry Industry Co., Ltd.
12.7. Elanco LLC
12.8. Endovac Animal Health, LLC
12.9. Heska Corporation
12.10. Hester Biosciences Limited
12.11. HIPRA, S.A.
12.12. Indian Immunologicals Limited
12.13. Merck KGaA
12.14. Neogen Corporation
12.15. Phibro Animal Health Corporation
12.16. Sanofi S.A.
12.17. Torigen Pharmaceuticals Inc.
12.18. Vaxxinova GmbH
12.19. VEROVACCiNES GmbH
12.20. Vetoquinol SA
12.21. Virbac, Inc.
12.22. Zoetis Inc.
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ANIMAL VACCINES MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. GLOBAL ANIMAL VACCINES MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2026
FIGURE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DNA VACCINES, 2018-2026 (USD MILLION)
FIGURE 10. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 11. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2020 VS 2026 (%)
FIGURE 18. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2026
FIGURE 20. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AQUA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AEROMONAS, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AEROMONAS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 24. GLOBAL ANIMAL VACCINES MARKET SIZE, BY STREPTOCOCCOSIS, 2018-2026 (USD MILLION)
FIGURE 25. GLOBAL ANIMAL VACCINES MARKET SIZE, BY STREPTOCOCCOSIS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 26. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIBRIO, 2018-2026 (USD MILLION)
FIGURE 27. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIBRIO, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 28. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE HERPES, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE HERPES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTEMPER, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTEMPER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL ANIMAL VACCINES MARKET SIZE, BY KENNEL COUGH, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL ANIMAL VACCINES MARKET SIZE, BY KENNEL COUGH, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 38. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LYME DISEASE, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LYME DISEASE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARVOVIRUS, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARVOVIRUS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 42. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES CANINE, 2018-2026 (USD MILLION)
FIGURE 43. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES CANINE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 44. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2026 (USD MILLION)
FIGURE 45. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FELINE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 46. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CALICIVIRUS, 2018-2026 (USD MILLION)
FIGURE 47. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CALICIVIRUS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 48. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS FELINE, 2018-2026 (USD MILLION)
FIGURE 49. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS FELINE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 50. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PANLEUKOPENIA, 2018-2026 (USD MILLION)
FIGURE 51. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PANLEUKOPENIA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 52. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES FELINE, 2018-2026 (USD MILLION)
FIGURE 53. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES FELINE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 54. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RHINOTRACHEITIS, 2018-2026 (USD MILLION)
FIGURE 55. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RHINOTRACHEITIS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 56. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2026 (USD MILLION)
FIGURE 57. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 58. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AVIAN INFLUENZA, 2018-2026 (USD MILLION)
FIGURE 59. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AVIAN INFLUENZA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 60. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INFECTIOUS BRONCHITIS, 2018-2026 (USD MILLION)
FIGURE 61. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 62. GLOBAL ANIMAL VACCINES MARKET SIZE, BY MAREK'S DISEASE, 2018-2026 (USD MILLION)
FIGURE 63. GLOBAL ANIMAL VACCINES MARKET SIZE, BY MAREK'S DISEASE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 64. GLOBAL ANIMAL VACCINES MARKET SIZE, BY NEWCASTLE DISEASE, 2018-2026 (USD MILLION)
FIGURE 65. GLOBAL ANIMAL VACCINES MARKET SIZE, BY NEWCASTLE DISEASE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 66. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SALMONELLA, 2018-2026 (USD MILLION)
FIGURE 67. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SALMONELLA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 68. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2026 (USD MILLION)
FIGURE 69. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 70. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS RUMINANTS, 2018-2026 (USD MILLION)
FIGURE 71. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS RUMINANTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 72. GLOBAL ANIMAL VACCINES MARKET SIZE, BY E. COLI, 2018-2026 (USD MILLION)
FIGURE 73. GLOBAL ANIMAL VACCINES MARKET SIZE, BY E. COLI, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 74. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE (FMD), 2018-2026 (USD MILLION)
FIGURE 75. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE (FMD), BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 76. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LUMPY SKIN, 2018-2026 (USD MILLION)
FIGURE 77. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LUMPY SKIN, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 78. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROTAVIRUS, 2018-2026 (USD MILLION)
FIGURE 79. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 80. AMERICAS ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 81. ARGENTINA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 82. BRAZIL ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 83. CANADA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 84. MEXICO ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 85. UNITED STATES ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 86. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 87. AUSTRALIA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 88. CHINA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 89. INDIA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 90. INDONESIA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 91. JAPAN ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 92. MALAYSIA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 93. PHILIPPINES ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 94. SINGAPORE ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 95. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 96. THAILAND ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 97. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 98. FRANCE ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 99. GERMANY ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 100. ITALY ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 101. NETHERLANDS ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 102. QATAR ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 103. RUSSIA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 104. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 105. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 106. SPAIN ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 107. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 108. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 109. GLOBAL ANIMAL VACCINES MARKET: FPNV POSITIONING MATRIX
FIGURE 110. GLOBAL ANIMAL VACCINES MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 111. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANIMAL VACCINES MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ANIMAL VACCINES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AQUA, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AEROMONAS, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL ANIMAL VACCINES MARKET SIZE, BY STREPTOCOCCOSIS, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIBRIO, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE HERPES, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTEMPER, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL ANIMAL VACCINES MARKET SIZE, BY KENNEL COUGH, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LYME DISEASE, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARVOVIRUS, BY REGION, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES CANINE, BY REGION, 2018-2026 (USD MILLION)
TABLE 23. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FELINE, BY REGION, 2018-2026 (USD MILLION)
TABLE 24. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CALICIVIRUS, BY REGION, 2018-2026 (USD MILLION)
TABLE 25. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS FELINE, BY REGION, 2018-2026 (USD MILLION)
TABLE 26. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PANLEUKOPENIA, BY REGION, 2018-2026 (USD MILLION)
TABLE 27. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES FELINE, BY REGION, 2018-2026 (USD MILLION)
TABLE 28. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RHINOTRACHEITIS, BY REGION, 2018-2026 (USD MILLION)
TABLE 29. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2026 (USD MILLION)
TABLE 30. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AVIAN INFLUENZA, BY REGION, 2018-2026 (USD MILLION)
TABLE 31. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY REGION, 2018-2026 (USD MILLION)
TABLE 32. GLOBAL ANIMAL VACCINES MARKET SIZE, BY MAREK'S DISEASE, BY REGION, 2018-2026 (USD MILLION)
TABLE 33. GLOBAL ANIMAL VACCINES MARKET SIZE, BY NEWCASTLE DISEASE, BY REGION, 2018-2026 (USD MILLION)
TABLE 34. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SALMONELLA, BY REGION, 2018-2026 (USD MILLION)
TABLE 35. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 36. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS RUMINANTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 37. GLOBAL ANIMAL VACCINES MARKET SIZE, BY E. COLI, BY REGION, 2018-2026 (USD MILLION)
TABLE 38. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE (FMD), BY REGION, 2018-2026 (USD MILLION)
TABLE 39. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LUMPY SKIN, BY REGION, 2018-2026 (USD MILLION)
TABLE 40. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY REGION, 2018-2026 (USD MILLION)
TABLE 41. AMERICAS ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. ARGENTINA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. BRAZIL ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. CANADA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. MEXICO ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. UNITED STATES ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. AUSTRALIA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. CHINA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. INDIA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. INDONESIA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. JAPAN ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. MALAYSIA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 54. PHILIPPINES ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 55. SINGAPORE ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 56. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 57. THAILAND ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 59. FRANCE ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 60. GERMANY ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 61. ITALY ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 62. NETHERLANDS ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 63. QATAR ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 64. RUSSIA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 65. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 66. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 67. SPAIN ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 68. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 69. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 70. GLOBAL ANIMAL VACCINES MARKET: SCORES
TABLE 71. GLOBAL ANIMAL VACCINES MARKET: BUSINESS STRATEGY
TABLE 72. GLOBAL ANIMAL VACCINES MARKET: PRODUCT SATISFACTION
TABLE 73. GLOBAL ANIMAL VACCINES MARKET: RANKING
TABLE 74. GLOBAL ANIMAL VACCINES MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 75. GLOBAL ANIMAL VACCINES MARKET: MERGER & ACQUISITION
TABLE 76. GLOBAL ANIMAL VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 77. GLOBAL ANIMAL VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 78. GLOBAL ANIMAL VACCINES MARKET: INVESTMENT & FUNDING
TABLE 79. GLOBAL ANIMAL VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 80. GLOBAL ANIMAL VACCINES MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook